Ozelle Unveils O-Cyte 1 at MEDICA 2026: A Leap in Hematology Diagnostics

At the recent MEDICA 2026 event in Düsseldorf, Ozelle made a significant impact by introducing their innovative hematology analyzer, the O-Cyte 1. This cutting-edge device integrates high-resolution cell imaging with routine blood tests, addressing the critical need for further evaluation when anomalies are detected in complete blood counts (CBCs). With the ability to provide visual contexts for cellular abnormalities, O-Cyte 1 seeks to enhance diagnostic efficiency in laboratory settings.

Enhancing Routine Analyses


The technology behind O-Cyte 1 is rooted in the AI × CBM (Complete Blood Morphology) model, which merges cellular imaging with AI-assisted morphological analysis. This system is particularly adept at differentiating leukocytes into seven distinct categories, facilitating a more nuanced understanding of blood samples. When testing is automated, the captured cellular images accompany the CBC results, allowing laboratory professionals to conduct deeper evaluations whenever necessary.

In high-throughput laboratories, such additional information is vital to seamlessly integrate into established workflows. O-Cyte 1 supports batching of 25 sample tubes, automatic sample identification using barcodes, automatic sample mixing, closed-tube sampling, and prioritization of urgent analyses. As a standalone unit, it can process up to 60 tests per hour, while a connectivity configuration of six units can achieve an impressive 360 tests per hour, significantly enhancing the laboratory's capacity as it scales up operations.

Practical Maintenance Features


Maintenance is another practical concern that O-Cyte 1 addresses effectively. Traditional analyzers with reusable fluid circuits typically require frequent cleaning, but the O-Cyte 1 simplifies this process by integrating essential fluid-contact components into a replaceable reagent kit. This integration minimizes the necessity for internal cleaning while incorporating built-in self-check functionalities that simplify troubleshooting and ongoing maintenance for distributors.

Jie Du, co-founder and head of R&D at Ozelle, remarked, “Our aim was to weave cellular morphology into routine hematological analyses while maintaining lab workflow efficiency. This approach necessitated designing the entire system with an emphasis on sample handling, image review, and maintenance.”

For clinics and decentralized diagnostic sites, expanding testing offerings in limited spaces while minimizing maintenance needs is crucial. Ozelle’s compact EHBT analyzer series, designed for human medicine, covers hematology, cellular imaging, immunoassays, and dry biochemistry. Additionally, the EHVT veterinary analyzer series provides hematology analysis, digital cell morphology analysis, immunoassays, biochemistry, and urine and stool testing. Both product lines prioritize reliable performance, user-friendliness, and minimal routine upkeep.

Live Demonstrations


Live demonstrations of the O-Cyte 1 system are ongoing until November 19 at Hall 1, Booth D63 of Messe Düsseldorf. Attendees have the opportunity to see the analyzer in action and discuss its clinical applications and distribution opportunities. For those interested in arranging a demonstration or meeting, Ozelle's team is available for engagement.

For more information about Ozelle and its products, visit www.ozellemed.com or reach out via email at [email protected].

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.